 |
1GWQ |
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1GWR |
HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1L2I |
Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1MVC |
Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist compound BMS 649 and a coactivator peptide |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T73 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxFF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T74 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T76 |
Crystal structure of the androgen receptor ligand binding domain in complex with a WxxVW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T79 |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLW motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7F |
Crystal structure of the androgen receptor ligand binding domain in complex with a LxxLL motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7M |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxYF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1T7R |
Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLF motif |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U3R |
Crystal Structure of Estrogen Receptor beta complexed with WAY-338 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U3S |
Crystal Structure of Estrogen Receptor beta complexed with WAY-797 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1U9E |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-397 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X76 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-697 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X78 |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH WAY-244 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7B |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH ERB-041 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1X7J |
CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA COMPLEXED WITH GENISTEIN |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1YYE |
Crystal structure of estrogen receptor beta complexed with way-202196 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
1ZAF |
Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one |
C |
A |
|
|
 |
2A3I |
Structural and Biochemical Mechanisms for the Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor |
B |
A |
|
|
 |
2BJ4 |
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST |
C |
A |
|
|
 |
2J7X |
STRUCTURE OF ESTRADIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2J7Y |
STRUCTURE OF 17-EPIESTRIOL-BOUND ESTROGEN RECEPTOR BETA LBD IN COMPLEX WITH LXXLL MOTIF FROM NCOA5 |
B |
A |
Nuclear receptor ligand-binding domain |
|
 |
2JF9 |
ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST |
P |
AC |
|
|
 |
2NV7 |
Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
3ERD |
HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE |
C |
A |
Nuclear receptor ligand-binding domain |
|
 |
3G8I |
Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes |
Z |
A |
|
|
 |
3G9E |
Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes |
B |
A |
|
|